Mayo Clinic 1

1. Advancing the global public health agenda for NAFLD: a consensus statement
2. Neurological, cardiac, musculoskeletal, and renal manifestations of scleroderma along with insights into its genetics, pathophysiology, diagnostic, and therapeutic updates
3. The case for simplifying and using absolute targets for viral hepatitis elimination goals
4. Bi-allelic variants in SPATA5L1 lead to intellectual disability, spastic-dystonic cerebral palsy, epilepsy, and hearing loss
5. Minimal information for studies of extracellular vesicles (MISEV2023): From basic to advanced approaches
1